Found 412 hits.
| 226 | Garcia-Diez, I.+, Curto-Barredo, L., Weller, K., Pujol, R. M., Maurer, M. and Giménez-Arnau, A. M.: Cross-cultural adaption of the urticaria control test from German to Castilian Spanish. Actas Dermosifiliogr. 2015: 106; 746-752. IF: N/A |
| 102. | Kolkhir, P., Pogorelow, D., Olisova, O., and Maurer, M.+: Comorbidity and pathogenic links of chronic spontaneous urticaria and systemic lupus erythematosus – a systemic review. Clin. Exp. Allergy 2016: 46; 275-287. IF: 5.26 |
| 56. | Maurer, M., Bader, M., Bas, M., Bossi, F., Cicardi, M., Cugno, M., Howarth, P., Kaplan, A., Kojda, G., Leeb-Lundberg, F., Lötvall, J., and Magerl, M.: New topics in bradykinin research. Allergy 2011: 66; 1397-1406. IF: 6.27 |
| 245(a) | Zazzali, J. L., Kaplan, A., Maurer, M. Raimundo, K., Trzaskoma, B., Antonova, E.+ N., and Rosén, K. E.: Comment on “Importance of angioedema-free days in patients with chronic idiopathic or spontaneous urticaria”. Ann. Allergy Asthma Immunol. 2017: 118; 524-526 |
| 433. | Cherrez-Ojeda, I.+, Vanegas, E., Cherrez, A., Felix, M., Weller, K., Magerl, M., Maurer, R. R., Mata, V. L., Kasperska-Zajac, A., Sikora, A., Fomina, D., Kovalkova, E., Godse, K., Rao, N. D., Khoshkhui, M., Rastgoo, S., Criado, R. F. J., Abuzakouk, M., Grandon, D., Van Doorn, M. B. A., Rodrigues Valle, S. O., Magalhaes, E., De Souza Lima, E. M., Thomsen, S. F., Ramón, G. D., Matos Benavides, E. E., Bauer, A., Giménez-Arnau, A. M., Kocatürk, E., Guillet, C., Larco, J. I., Zhao, Z. T., Makris, M., Ritchie, C., Xepapadaki, P., Ensina, L. F., Cherrez, S., and Maurer, M.: How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study. World Allergy Organ. J. 2021: 14; e100542. IF: 5.52 |
o.433
| 259 | Hawro, T., Lehmann, S., Altrichter, S., Fluhr, J. W., Zuberbier, T., Church, M. K., Maurer, M.+ and Metz, M.: Skin provocation tests may help to diagnose atopic dermatitis. Allergy 2016: 71; 1745-1752. IF: 7.36 |
|
489. |
Kröger, M.+, Scheffel, J., Shirshin, E. A., Schleusener, J., Meinke, M. C., Lademann, J., Maurer, M., and Darvin, M. E.: Label-free imaging of M1 and M2 macrophage phenotypes in the human dermis in vivo using two-photon excited FLIM. ELIFE 2022: 11; e72819. IF: 7.70 |
o.489
| 436. | Bonnekoh, H., Frischbutter, S., Roll, S., Maurer, M., and Krause, K.+: Tocilizumab treatment in patients with Schnitzler syndrome: an open-label study. J. Allergy Clin. Immunol. Pract. 2021: 9; 2486-2489. IF: 11.02 |
o.436
|
440. |
Farkas, H., Stobiecki, M., Peter, J., Kinaciyan, T., Maurer, M., Aygören-Pürsün, E., Kiani-Alikhan, S., Wu, A., Reshef, A., Bygum, A., Fain, O., Hagin, D., Huissoon, A., Jeseňák, M., Lindsay, K., Grivcheva Panovska, V., Smith, W., Steiner, U. C., Zubrinich, C., Best, J. M., Cornprobst, M., Dix, D., Dobo, S. M., Iocca, H. A., Murray, S. C., Nagy, E., Nagy, E., and Sheridan, W. P.+: Long-term safety and effectiveness of berotralstat for hereditary angioedema: the open-label APeX-S study. Clin. Transl. Allergy 2021: 11; e12035. IF: 5.66 |
o.440
|
480. |
Altrichter, S., Staubach, P., Pasha, M., Sing, B., Chang, A. T., Bernstein, J. A., Rasmussen, H. S., Siebenhaar, F., and Maurer, M.+: An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria. J. Allergy Clin. Immunol. 2022: 149; 1683-1690. IF: 14.20 |
o.480